These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17060)

  • 21. Beta blocking drugs and the treatment of hypertension.
    Hammond JJ; Kirkendall WM
    Tex Med; 1978 Jul; 74(7):43-8. PubMed ID: 27876
    [No Abstract]   [Full Text] [Related]  

  • 22. [Adrenergic beta receptor blockaders in arterial hypertension].
    Rodríguez-Navarro CQ; Maceira Cruz B; Fernández Andrade C; Ortega Amaya J; Garcia de Pesquera F; López Solbes R; Castilla Jiménez J; Mateos Aguilar J
    Rev Clin Esp; 1975 Nov; 139(4):345-51. PubMed ID: 1828
    [No Abstract]   [Full Text] [Related]  

  • 23. [Use of beta-receptor blocking agents in the treatment of arterial hypertension].
    Hilden T; Ibsen H
    Ugeskr Laeger; 1973 May; 135(20):961-4. PubMed ID: 4148294
    [No Abstract]   [Full Text] [Related]  

  • 24. "Tailored" application of beta-blockers in hypertension: a continuing dilemma.
    Birkenhäger WH; de Leeuw PW; Wester A; Kho TL; Vandongen R; Falke HE
    Neth J Med; 1977; 20(3):116-22. PubMed ID: 18688
    [No Abstract]   [Full Text] [Related]  

  • 25. [The potential of beta-blockaders in the management of hypertension].
    Bühler FR; Kowski W; Bolli P; Bertel O
    Internist (Berl); 1978 Sep; 19(9):510-9. PubMed ID: 29849
    [No Abstract]   [Full Text] [Related]  

  • 26. [Propanolol in arterial hypertension. Beta-blockaders. Recent advances].
    Arauco R; Alagón A
    Prensa Med Mex; 1979; 44(5-6):97-104. PubMed ID: 45356
    [No Abstract]   [Full Text] [Related]  

  • 27. Plasma renin activity in hyper- and hypothyroidism: effect of adrenergic blocking agents.
    Hauger-Klevene JH; Brown H; Zavaleta J
    J Clin Endocrinol Metab; 1972 Apr; 34(4):625-9. PubMed ID: 4401157
    [No Abstract]   [Full Text] [Related]  

  • 28. Pathophysiology of propranolol in hypertension.
    Frohlich ED
    South Med J; 1977 Jan; 70(1):95-9. PubMed ID: 14402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Studies on the influence of a beta-receptor blocking agent on plasma renin activity in man].
    Distler A; Abdelhamid S; Philippi A; Rahn KH
    Verh Dtsch Ges Inn Med; 1971; 77():937-9. PubMed ID: 4405363
    [No Abstract]   [Full Text] [Related]  

  • 30. Hemodynamic and adrenergic responses of bevantolol and propranolol in hypertensives.
    Snedden W; Fernandez PG; Vasdev S; Bolli P
    Can J Cardiol; 1989; 5(1):37-41. PubMed ID: 2563955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta blocking agents in cardiovascular diseases.
    Bordia A; Khabya BL
    Indian Heart J Teach Ser; 1976 Jun; 1(1):11-5. PubMed ID: 27449
    [No Abstract]   [Full Text] [Related]  

  • 32. [Beta-blocking agents in essential hypertension].
    Sakaguchi A; Ikeda M
    Nihon Rinsho; 1979 Oct; 37(10):3499-502. PubMed ID: 42818
    [No Abstract]   [Full Text] [Related]  

  • 33. [Action of 3-beta adrenolytics on plasma renin activity measured by radioimmunology in genetically hypertensive rats].
    Pape D; Lacroix P; Linée P; Le Pollés JB; Van den Driessche J
    C R Seances Soc Biol Fil; 1977; 171(1):224-8. PubMed ID: 20200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodynamic effects of nifedipine in hypertension in the presence of elevated angiotensin-II and beta-adrenergic blockade.
    Blau A; Battler A; Eldar M; Rath S; Neufeld HN; Kapuler S; Iaina A; Cohen D; Eliahou HE
    J Clin Hypertens; 1986 Mar; 2(1):13-20. PubMed ID: 2873210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hypotensive and renin-stimulating action of captopril at first and during treatment with a beta-blocker].
    Bianchini C; Terzoli L; Leonetti G; Banfi E; Castelli D; Zanchetti A
    Cardiologia; 1982; 27(4):381-5. PubMed ID: 6152734
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pharmacological basis of the symptomatic treatment of arterial hypertension. I. Hemodynamic effects, mechanisms of action and side effects of antihypertensive agents].
    Fournier A; Lagrue G; Schmitt H
    Nouv Presse Med; 1973 Oct; 2(38):2539-46. PubMed ID: 4148700
    [No Abstract]   [Full Text] [Related]  

  • 37. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison of the hemodynamic effects in man of 2 beta-blockaders: propranolol and practolol].
    Ambrosioni E; Bracchetti D; Russo F; Catizone L; Perri G; Magnani B
    Boll Soc Ital Cardiol; 1972; 17(2):91-101. PubMed ID: 4403643
    [No Abstract]   [Full Text] [Related]  

  • 39. Beta-blockers and the kidney.
    Epstein M; Oster JR
    Miner Electrolyte Metab; 1982 Nov; 8(5):237-54. PubMed ID: 6132329
    [No Abstract]   [Full Text] [Related]  

  • 40. Vasodilation in treatment of hypertension.
    Chidsey CA
    N Engl J Med; 1970 May; 282(19):1102-3. PubMed ID: 4392414
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.